Antioxidative metabolism in Down syndrome

Area of Science:

• Biochemistry
• Genetics
• Pediatrics

Background:

• Down syndrome, the most common cause of intellectual disability, affects 1 in 700-800 infants.
• Biochemical abnormalities in Down syndrome are linked to chromosome 21 gene dosage, including altered antioxidant defense systems.
• Overproduction of superoxide dismutase (SOD-1) is a known consequence of the extra chromosome.

Purpose of the Study:

• To investigate the activities of SOD-1 and glutathione peroxidase (GSH-Px) in Down syndrome patients.
• To measure plasma levels of essential cofactors: zinc (Zn), copper (Cu), and selenium (Se).
• To compare these biochemical markers between Down syndrome patients and healthy controls.

Main Methods:

• Plasma samples were collected from 20 Down syndrome patients and 15 age/sex-matched controls.
• Enzyme activities for SOD-1 and GSH-Px were measured.
• Concentrations of Zn, Cu, and Se were determined using appropriate analytical techniques.

Main Results:

• Plasma activities of GSH-Px and SOD were significantly lower in Down syndrome patients compared to controls.
• Plasma copper (Cu) levels were also significantly decreased in the patient group.
• Zinc (Zn) and selenium (Se) concentrations did not show significant differences between the groups.

Conclusions:

• Down syndrome is associated with reduced activity of key antioxidant enzymes, SOD-1 and GSH-Px.
• Copper levels are diminished in individuals with Down syndrome, potentially impacting antioxidant function.
• Further research is needed to clarify the precise mechanisms and implications of these biochemical alterations.